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Background: The Hamilton Depression Rating Scale (HAM-D) is commonly used as a screening instrument, as a
continuous measure of change in depressive symptoms over time, and as a means to compare the relative efficacy
of treatments. Among several abridged versions, the 6-item HAM-D6 is used most widely in large degree because
of its good psychometric properties. The current study compares both self-report and clinician-rated versions of the
Hebrew version of this scale.
Methods: A total of 153 Israelis 75 years of age on average participated in this study. The HAM-D6 was examined
using confirmatory factor analytic (CFA) models separately for both patient and clinician responses.
Results: Reponses to the HAM-D6 suggest that this instrument measures a unidimensional construct with each of
the scales’ six items contributing significantly to the measurement. Comparisons between self-report and clinician
versions indicate that responses do not significantly differ for 4 of the 6 items. Moreover, 100% sensitivity (and 91%
specificity) was found between patient HAM-D6 responses and clinician diagnoses of depression.
Conclusion: These results indicate that the Hebrew HAM-D6 can be used to measure and screen for depressive
symptoms among elderly patients.
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Depression is a common debilitative psychiatric condi-
tion ranked high in prevalence among all mental health
conditions [1]. Lifetime prevalence may be as high as
20% [2] and, at any one time, 5–10% of the world’s
population meets diagnostic criteria for a major depres-
sive episode [3]. Depression is projected to be the sec-
ond leading cause of disability worldwide in 2020 [4].
Clinical depression is common in primary care with
rates of prevalence among older adults ranging between
4–24% [5,6]. Untreated elderly patients are at higher risk
of morbidity and mortality [7] and experience slower* Correspondence: Bachner@bgu.ac.il
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reproduction in any medium, provided the orrates of recovery [6,8]. Moreover, chronic depression is a
significant risk factor for dementia [9].
Given that depression is amenable to treatment, valid
and reliable screening tools are necessary to identify this
patient population. Among existing instruments, the
clinician-administered Hamilton Depression Rating
Scale (HAM-D) was first developed to assess the efficacy
of the first generation of antidepressant medications
[10]; the HAM-D has since become the gold standard
for measuring symptom severity and change in rando-
mized clinical trials. Among various formats (17, 21, 24
& 28 items) [10,11], the 17-item (HAM-D17) has been
used most frequently. Scale items measure mood, in-
somnia, anhedonia, agitation, gastro-intestinal and other
somatic symptoms, weight change, suicidal ideation,
hypochondriasis, anosognosia, and psychomotor and
cognitive retardation.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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questioned whether the HAM-D17 is a unidimensional
or multidimensional instrument [12-15]. This is prob-
lematic as multi-factorial measurement may impede the
detection of symptom change over time, treatment re-
sponse characteristics [16] and the ability to distinguish
the relative efficacy of treatments [13]. This assertion is
supported by meta-analytic study findings indicating that
certain scale items are less sensitive to measurement of
symptom severity. In addition, some items have com-
paratively poor inter-rater and retest reliability, and the
response-option format may not be optimal [17]. In light
of these findings, some have suggested that the 17-item
HAM-D may be less than ideal for clinical research
applications [14,15,17,18].
These limitations have led researchers to propose
abridged versions of the HAM-D that are quick to ad-
minister yet sensitive to measurement of symptom
levels, change over time and relative differences in treat-
ment efficacy. For instance, Maier and Philipp [19] pro-
posed a 6-item version of the HAM-D. More recently,
an 8-item version was devised by Gibbons and collea-
gues [20] by applying item response theory. Research to
date suggests that both versions are sensitive to change
over time and can identify patients in remission [21,22].
Recently, a scale consisting of 7 items was also suggested
[23]. The items were empirically identified on the basis
of response frequency and sensitivity to change of the
individual HAM-D items with depressed samples [24].
Among the abridged versions of the Hamilton scale,
the most frequently used was developed by Bech et al.
(HAM-D6) [25]. Using item analysis, these researchers
[25] have proposed a 6-item HAM-D as a unidimen-
sional measure of depressive symptomatology [14]. This
HAM-D6 is composed of items measuring core symptoms
of depression (i.e., depressed mood, self-esteem and feel-
ings of guilt, social interaction and interests, psychomotor
retardation, anxiety, and somatic symptoms). Compared
to the HAM-D17, this assessment appears to measure a
unidimensional construct [13-15,17,25,26], and it is as
sensitive [14] or more sensitive in detecting drug–placebo
or drug–drug differences [27,28]. The authors of a recent
study with older adults that compared six depression
scales concluded that the HAM-D6 was the only one to
demonstrate total scalability, and that it had the greatest
external validity [18].
This scale, may be especially appropriate for use by both
older persons and clinicians; its relative brevity makes it
comparatively easy for older persons to complete and clini-
cians to administer. However, to the best of our knowledge,
the psychometric properties of responses to the Hebrew
HAM-D6 had yet to be examined. Thus, the current study
examined and compared self-report and clinician res-
ponses to the Hebrew HAM-D6 for elderly patients.Methods
Scale translation
The HAM-D6 was first translated from English to Hebrew
by a bilingual psychologist, in keeping with accepted pro-
cedures [29]. The translated version was back transla-
ted and modified until it was comparable to the original
version.
Training procedures
Two graduate research assistants completed a three-day
training course in the administration of study measures.
After watching a training tape and receiving instructions,
they administered study measures in mock interviews
until acceptable inter-rater reliability was established
vis-à-vis semi-structured clinical assessments. Research
assistants’ HAM-D6 scores did not significantly differ
from corresponding patient HAM-D responses suggest-
ing no discernible between-rater differences, χ2 (df = 1)
= 1.31, p = .25.
Recruitment
Participants were recruited in the waiting rooms of two
primary care clinics operated by Clalit Health Services
(Israel’s largest health insurance provided serving 53% of
the population). One clinic is located in the center and
the other in the north of Israel (Tel Aviv and Haifa,
respectively). Inclusion criteria were: 60+ years of age,
fluent in Hebrew, and no pronounced cognitive loss
(determined using a 6-item screening measure [30]).
Participant recruitment took place between May, 2008
and February, 2009.
Research assistants approached patients to request
their participation in this study. Participation was volun-
tary and no remuneration was provided. Those who took
part provided written consent. This study was approved
by the Helsinki Committee of the Clalit Health Care
Services.
Measures
The Structured Clinical Interview for DSM-IV (SCID-I)
The SCID-I is a semi-structured interview to assist clini-
cians in making a DSM-IV Axis I diagnosis [31]. Only
those modules pertaining to depression and dysthymia
were administered in the present study. The Hebrew
version of the SCID-I was translated and validated by
Shalev et al. [32]. All study participants were interviewed
using this instrument.
The 6-item Hamilton (HAM-D6)
The self- and clinician-administered versions of the
HAM-D6 measure depressed mood, self-esteem and
guilt, social interaction and interests, psychomotor re-
tardation, anxiety, and somatic symptoms. Items are
provided along 5-point scales, with the exception of the
2. Self-esteem and guilt
3. Social interaction and interests
1. Depressed mood
4. Psychomotor retardation
5. Anxiety
6. Somatic symptoms
.83 *
.66 (8.58)
.81 (11.0)
.58 (7.36)
.80 (10.9)
.64 (8.22)
Depressive 
Symptoms
Older Patient HAM-D Models of Responses
Figure 1 Older patient HAM-D models of responses. Note: Maximum likelihood estimates (standardize solution and significance levels). Asterisks
(*) denote parameters initially fixed to 1.0 for purposes of scaling and statistical identification. Significance estimates cannot be computed for these
two items.
Bachner et al. BMC Psychiatry 2013, 13:2 Page 3 of 6
http://www.biomedcentral.com/1471-244X/13/2somatic symptoms item (where responses were provided
on a 3-point scale). As a screening measure, scores of
7+ suggest clinically significant depressive symptomatol-
ogy [33]. Whereas the self-report HAM-D6 is based
solely on patient responses, the clinician-administered
version integrates patients’ responses and clinical ob-
servation.
Analytic strategy
We set out to ascertain if the HAM-D6 measures a uni-
dimensional construct, as proposed by Bech et al. [25].
This hypothesis was tested using confirmatory factor
analyses. Both self- and clinician-administered versions
of the HAM-D6 were next compared to assess the
relative contribution of items to measurement (in-
variance or equivalence analyses). Subsequent analyses
were undertaken comparing responses for each patient1. Depressed mood
2. Self-esteem and guilt
3. Social interaction and interests
4. Psychomotor retardation
5. Anxiety
6. Somatic symptoms
Clinician 6-Item HAM-D Responses
Figure 2 Clinician 6-Item HAM-D responses. Note: Maximum likelihood e
parameters initially fixed to 1.0 for purposes of scaling and statistical identifica(self and corresponding clinician HAM-D6 responses).
Comparisons between SCID diagnoses of a major de-
pressive episode and the patient HAM-D6 responses
were made to estimate sensitivity and specificity of the
scale. Lastly, item-level analyses were computed (intra-
class correlation coefficients) to determine if there was
agreement between patients and their clinicians for each
item.Results
This sample was composed of 153 patients 75 years of
age on average (range 59–98; SD = 8.1). The majority of
participants were male (91/153 or 59.5%). Eighty seven
(56.9%) were currently married and living with a spouse,
54 (35.3%) were widowed, and 12 (8.8%) were divorced
or lived alone. Respondents’ mean level of education wasDepressive 
Symptoms
.77 *
.72 (8.57)
.76 (8.97)
.27 (3.10)
.77 (9.14)
.59 (6.94)
stimates (standardize solution and significance levels). Asterisks (*) denote
tion. Significance estimates cannot be computed for these two items.
Table 1 Invariance analyses of older patient and clinician 6-Item HAM-D responses
Model df χ 2 Δdf Δ χ 2 AGFI SRMR CFI RMSEA
(RMSEA-CL90)
1. Baseline 17 30.745 – – .93 .0352 .98 .052 (.020 – .081)
2. Self-esteem and guilt 18 31.901 1 1.156 .93 .0348 .98 .051 (.019 – .079)
3. Social interaction and interests 19 36.796 1 4.896 ** .92 .0348 .97 .056 (.028 – .083)
4. Psychomotor retardation 20 67.602 1 30.806 ** .86 .0746 .93 .089 (.066 – .113)
5. Anxiety 21 69.090 1 1.488 .87 .0756 .93 .087 (.065 – .110)
6. Somatic symptoms 22 69.127 1 0.037 .87 .0759 .93 .084 (.062 – .107)
Note. df = degrees of freedom, AGFI = Adjusted Goodness of Fit Index, SRMR = Standardized Root Mean Residual, CFI = Comparative Fit Index, RMSEA = Root Mean
Square Error of Approximation, CL90 = 90% Confidence Limits.
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(63.4%) ranked their economic status as fair.HAM-D6 as a screening measure
As previously mentioned, Bech et al. [33] suggest that a
HAM-D6 score of 7+ is suggestive of clinically signi-
ficant depressive symptoms (i.e., warranting thorough
clinical assessment). Comparing patient and clinician
ratings, agreement as calculated using the kappa coeffi-
cient was in fair range (k = .26; [34]). Where there was a
discrepancy between the two, 13 patients provided
responses in clinical range, whereas physicians’ res-
ponses indicated these patients were euthymic. A similar
finding emerged comparing patient HAM-D6 responses
with SCID diagnoses of a current major depressive epi-
sode (k = .20; linear weighted). Where there was a dis-
crepancy, 14 patients provided HAM-D6 responses in
clinical range, while the SCID diagnoses indicated no
major depressive episode. However, these percentages
indicate 100% sensitivity for the patient version of the
HAM-D6 (true positives) and 91% specificity (true
negatives).Confirmatory factor analytic models
Confirmatory factor analytic (CFA) models were com-
puted separately for older patients (χ2[df = 7] = 23.80,
p < .01) and corresponding clinician HAM-D6 scores,
(χ2[df = 9] = 16.93, p = .05). Goodness of fit indices for
both models were within optimal parameters [35].Table 2 Intra-class correlation coefficients between older
patient and clinician HAM-D6 responses
Item ICC
1. Depressed mood .78
2. Self-esteem and guilt .73
3. Social interaction and interests .74
4. Psychomotor retardation .12
5. Anxiety .62
6. Somatic symptoms .64Moreover, each of the six items contributed significantly
to measurement of a single higher-order construct (i.e.,
all item t values > 1.96); see Figures 1 and 2. For both pa-
tient and clinician versions, the HAM-D6 appears to
measure a unidimensional depression construct.
Next, invariance analyses were undertaken to compare
solutions between CFA models. These analyses indicated
that responses did not significantly differ for 4 of 6
items. However, responses for the social interaction and
interests and psychomotor retardation items did differ.
Both contributed to measurement of depression as re-
ported by patients to a greater degree than that reported
by the clinicians. See Table 1.
Intra-class correlation coefficients
Intra-class correlation coefficients (ICC) were next com-
puted to directly compare HAM-D6 ratings for patient–
clinician pairings (i.e., patient self-report vs. correspond-
ing clinician ratings for that patient). ICC values were
within adequate parameters for items 1–3 (depressed
mood, self-esteem and guilt, social interaction and inter-
ests), low for items 5–6 (anxiety, somatic symptoms),
but very low for item 4 (psychomotor retardation). This
is consistent with invariance analyses reported above,
see Table 2.
Discussion
The goal of this study was to assess the psychometric
properties of self-report vs. clinician versions on the
Hebrew HAM-D6. Results indicated that each of the six
scale items contributed significantly to the measurement
(both for patients and clinicians) and that HAM-D6
responses indeed measure a single depression construct.
These findings are in accord with previously reported
findings [13-15,25,26,33].
Comparing clinician and patient HAM-D6 responses
indicate satisfactory correspondence between the two.
Moreover, when patient HAM-D6 responses were com-
pared to SCID diagnoses of major depressive episodes,
sensitivity and specificity were measured as 100% and
91%, respectively.
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effective threshold value. Most notably, responses by
older adults, themselves, enable effective depression
screening between euthymic patients and those report-
ing pronounced depressive symptomatology.
In addition, findings indicate that responses do not dif-
fer significantly for 4 of the 6 items suggesting that
patients and clinicians appear to interpret and respond
to these HAM-D6 items in a consistent manner. Further-
more, the intra-class correlations for 5 of the 6 items
were found to be above 0.60. This congruence between
patients and clinicians for most scale items implies that
patients’ responses can be trusted and accepted as a
valid evaluation of depression.
Responses do differ, however, for the social interaction
and interests and psychomotor retardation items. For
both items, patients’ responses contributed more to the
measurement of depression than clinicians’ responses.
Furthermore, the intra-correlation coefficient for the
psychomotor retardation was found to be very low, but
for the social interaction and interests item, an adequate
correlation emerged.
In light of these intriguing results, we re-examined the
Hebrew translations in order to ascertain where refine-
ments are warranted. In English, the second response
option for the social interaction and interests item reads:
“I have felt that I have had difficulty performing my daily
activities, but I was still able to perform them with great
effort.” The current Hebrew wording translates to: “I
had difficulty performing my daily activities, but I was
still able to perform routine activities”.
The fourth response of this item in English reads: “I
have not been able to do any of the simplest day-to-day
activities without help,” and the current Hebrew wording
translates to: “I have not been able to do any of the sim-
ple day-to-day activities without help.” Although the dif-
ference appears minimal, it might have had an effect on
the results.
In English, the third and fourth response options for
the psychomotor retardation item reads: “I have felt
clearly slowed down or subdued or have been talking
much less than usual,” and “I have hardly been talking at
all or feel extremely slowed down at the time.” The cor-
responding Hebrew wording translates to: “I have felt
clearly slowed down or passive and have been talking
much less than usual,” and “I have hardly been talking at
all and feel extremely slowed down all the time.” We
recommend that corrections in translation be made for
future studies using the self-report Hebrew HAM-D6.
Several limitations of the study need to be acknowl-
edged: a) we do not have data on non-participants and
cannot compare this group to our sample, b) we do not
have medication data for this sample, c) this is a rela-
tively small sample size, and d) the research assistantsthat assessed the participants SCID were aware of their
HAM-D6 scores. Therefore, future studies need to
examine the Hebrew HAM-D6 with larger samples of
participants from different age groups derived by ran-
dom recruitment.
Conclusion
Nonetheless, in the light of our results, the Hebrew
HAM-D6 can be used to measure and screen depressive
symptoms among elderly persons. Future psychometric
research is required to ascertain whether the above sug-
gested revisions will further improve the psychometric
properties of responses to this Hebrew version of the
HAM-D6.
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